Veterinary regenerative medicine market was valued at US$ 345.4 million in 2024 and is projected to hit the market valuation of US$ 1,045.9 million by 2033 at a CAGR of 13.1% during the forecast period 2025–2033.
Central nervous system therapeutic market was valued at US$ 129.38 billion in 2024 and is projected to hit the market valuation of US$ 235.87 billion by 2033 at a CAGR of 6.90% during the forecast period 2025–2033.
Saliva collection and diagnostics market was valued at US$ 826.6 million in 2024 and is projected to hit the market valuation of US$ 1,260.5 million by 2033 at a CAGR of 4.8% during the forecast period 2025–2033.
Viral vectors & plasmid DNA manufacturing market was valued at US$ 4.21 billion in 2024 and is projected to hit the market valuation of US$ 20.30 billion by 2033 at a CAGR of 19.1% during the forecast period 2025–2033.
US mRNA therapeutics CDMO market was valued at US$ 1.78 billion in 2024 and is projected to hit the market valuation of US$ 6.27 billion by 2033 at a CAGR of 15.01% during the forecast period 2025–2033.
The traumatic brain injury (TBI) market is expected to witness significant growth, with revenues projected to increase from USD 2.5 billion in 2024 to USD 4.7 billion by 2033, registering a strong CAGR of 7.2% during the forecast period.
Complementary and alternative medicine market was valued at US$ 193.36 billion in 2024 and is projected to hit the market valuation of US$ 1,282.70 billion by 2033 at a CAGR of 23.56% during the forecast period 2025–2033.
The glioblastoma multiforme treatment market is projected to grow from USD 3.0 billion in 2024 to USD 6.1 billion by 2033, registering a compound annual growth rate (CAGR) of 8.5% during the forecast period.